Annual Meeting

Connecting ALS Researchers from Around the World

Each spring, the Target ALS Annual Meeting brings members of our Innovation Ecosystem together over three days to share the latest breakthroughs and forge new collaborations, driving progress toward effective treatments for ALS. Our 2024 meeting had the largest attendance in history, with over 850 attendees present from academic institutions, pharmaceutical and biotech companies, venture capital firms and nonprofit organizations – both in-person and virtually – reflecting the growth of both our funded portfolio of scientists and the impact our work has had on expanding ALS research.

The Target ALS Annual Meeting is hailed as the premier ALS conference globally. What makes it so unique? First, members of our Innovation Ecosystem present confidential information about their ongoing research – unpublished work that is truly on the cutting-edge – and receive real-time feedback from other experts in the field. Second, the presence of every stakeholder in a single room creates an atmosphere ripe for collaboration between groups that don’t naturally intermingle. The collaborations that have formed at previous Annual Meetings have had a storied impact on the research landscape. By connecting academic researchers with pharmaceutical and biotech representatives and venture capitalists, research is able to move rapidly from the laboratory to the clinic.

As the Innovation Ecosystem grows, each year’s Annual Meeting brings a new sense of excitement and a renewed hope that a future where Everyone Lives is even closer on the horizon. We’re looking forward to forging new collaborations and sharing the latest breakthroughs at our next Annual Meeting, which will be held from May 6-8, 2025 at the Renaissance Boston Waterfront in Boston, Massachusetts, USA. The conference is by invitation only to accommodate members of our growing Innovation Ecosystem.